Literature DB >> 18256699

3' end mRNA processing: molecular mechanisms and implications for health and disease.

Sven Danckwardt1, Matthias W Hentze, Andreas E Kulozik.   

Abstract

Recent advances in the understanding of the molecular mechanism of mRNA 3' end processing have uncovered a previously unanticipated integrated network of transcriptional and RNA-processing mechanisms. A variety of human diseases impressively reflect the importance of the precision of the complex 3' end-processing machinery and gene specific deregulation of 3' end processing can result from mutations of RNA sequence elements that bind key specific processing factors. Interestingly, more general deregulation of 3' end processing can be caused either by mutations of these processing factors or by the disturbance of the well-coordinated equilibrium between these factors. From a medical perspective, both loss of function and gain of function can be functionally relevant, and an increasing number of different disease entities exemplifies that inappropriate 3' end formation of human mRNAs can have a tremendous impact on health and disease. Here, we review the mechanistic hallmarks of mRNA 3' end processing, highlight the medical relevance of deregulation of this important step of mRNA maturation and illustrate the implications for diagnostic and therapeutic strategies.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18256699      PMCID: PMC2241648          DOI: 10.1038/sj.emboj.7601932

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  202 in total

Review 1.  Mechanisms of alternative pre-messenger RNA splicing.

Authors:  Douglas L Black
Journal:  Annu Rev Biochem       Date:  2003-02-27       Impact factor: 23.643

2.  Association of polyadenylation cleavage factor I with U1 snRNP.

Authors:  Sita Awasthi; James C Alwine
Journal:  RNA       Date:  2003-11       Impact factor: 4.942

3.  Budd-Chiari syndrome in a patient heterozygous for the point mutation C20221T of the prothrombin gene.

Authors:  Z Balim; B Kosova; K Falzon; S Bezzina Wettinger; Y Colak
Journal:  J Thromb Haemost       Date:  2003-04       Impact factor: 5.824

4.  Prothrombin gene variants in non-Caucasians with fetal loss and intrauterine growth retardation.

Authors:  Iris Schrijver; Tiffanee J Lenzi; Carol D Jones; Marla J Lay; Maurice L Druzin; James L Zehnder
Journal:  J Mol Diagn       Date:  2003-11       Impact factor: 5.568

5.  Polymorphisms in fatty acid-binding protein-3 (FABP3) - putative association with type 2 diabetes mellitus.

Authors:  Hyoung Doo Shin; Lyoung Hyo Kim; Byung Lae Park; Hye Seung Jung; Young Min Cho; Min Kyong Moon; Hong Kyu Lee; Kyong Soo Park
Journal:  Hum Mutat       Date:  2003-08       Impact factor: 4.878

6.  Genetic variation in lectin-like oxidized low-density lipoprotein receptor 1 (LOX1) gene and the risk of coronary artery disease.

Authors:  Qi Chen; Steven E Reis; Candace Kammerer; Wendy Y Craig; Sue E LaPierre; Erin Luedecking Zimmer; Dennis M McNamara; Daniel F Pauly; Barry Sharaf; Richard Holubkov; C Noel Bairey Merz; George Sopko; Franklin Bontempo; M Ilyas Kamboh
Journal:  Circulation       Date:  2003-06-16       Impact factor: 29.690

7.  Fabry disease: novel alpha-galactosidase A 3'-terminal mutations result in multiple transcripts due to aberrant 3'-end formation.

Authors:  Makiko Yasuda; Junaid Shabbeer; Makiko Osawa; Robert J Desnick
Journal:  Am J Hum Genet       Date:  2003-06-06       Impact factor: 11.025

8.  Association of 3'-UTR polymorphisms of the oxidised LDL receptor 1 (OLR1) gene with Alzheimer's disease.

Authors:  J-C Lambert; E Luedecking-Zimmer; S Merrot; A Hayes; U Thaker; P Desai; A Houzet; X Hermant; D Cottel; A Pritchard; T Iwatsubo; F Pasquier; B Frigard; P M Conneally; M-C Chartier-Harlin; S T DeKosky; C Lendon; D Mann; M I Kamboh; P Amouyel
Journal:  J Med Genet       Date:  2003-06       Impact factor: 6.318

9.  Sequence determinants in human polyadenylation site selection.

Authors:  Matthieu Legendre; Daniel Gautheret
Journal:  BMC Genomics       Date:  2003-02-25       Impact factor: 3.969

Review 10.  Poly(A)-binding proteins: multifunctional scaffolds for the post-transcriptional control of gene expression.

Authors:  David A Mangus; Matthew C Evans; Allan Jacobson
Journal:  Genome Biol       Date:  2003-07-01       Impact factor: 13.583

View more
  140 in total

1.  Cloning and characterization of buffalo NANOG gene: alternative transcription start sites, splicing, and polyadenylation in embryonic stem cell-like cells.

Authors:  Natwar Singh; Ruchi Sharma; Aman George; Suresh K Singla; Prabhat Palta; Radhaysham Manik; Manmohan S Chauhan; Dheer Singh
Journal:  DNA Cell Biol       Date:  2011-10-19       Impact factor: 3.311

2.  Genome-wide determination of a broad ESRP-regulated posttranscriptional network by high-throughput sequencing.

Authors:  Kimberly A Dittmar; Peng Jiang; Juw Won Park; Karine Amirikian; Ji Wan; Shihao Shen; Yi Xing; Russell P Carstens
Journal:  Mol Cell Biol       Date:  2012-02-21       Impact factor: 4.272

Review 3.  Orphan nuclear bodies.

Authors:  Maria Carmo-Fonseca; Maria T Berciano; Miguel Lafarga
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-07-07       Impact factor: 10.005

Review 4.  To polyadenylate or to deadenylate: that is the question.

Authors:  Xiaokan Zhang; Anders Virtanen; Frida E Kleiman
Journal:  Cell Cycle       Date:  2010-11-15       Impact factor: 4.534

5.  A systems genetic analysis of alcohol drinking by mice, rats and men: influence of brain GABAergic transmission.

Authors:  Laura M Saba; Beth Bennett; Paula L Hoffman; Kelsey Barcomb; Takao Ishii; Katerina Kechris; Boris Tabakoff
Journal:  Neuropharmacology       Date:  2010-12-23       Impact factor: 5.250

Review 6.  Tissue-specific mechanisms of alternative polyadenylation: testis, brain, and beyond.

Authors:  Clinton C MacDonald; K Wyatt McMahon
Journal:  Wiley Interdiscip Rev RNA       Date:  2010 Nov-Dec       Impact factor: 9.957

Review 7.  Connections between 3'-end processing and DNA damage response.

Authors:  Murat A Cevher; Frida E Kleiman
Journal:  Wiley Interdiscip Rev RNA       Date:  2010-05-25       Impact factor: 9.957

Review 8.  Pre-mRNA 3'-end processing complex assembly and function.

Authors:  Serena Chan; Eun-A Choi; Yongsheng Shi
Journal:  Wiley Interdiscip Rev RNA       Date:  2010-10-18       Impact factor: 9.957

9.  U1 snRNP-mediated poly(A) site suppression: beneficial and deleterious for mRNA fate.

Authors:  Jörg Langemeier; Maximilian Radtke; Jens Bohne
Journal:  RNA Biol       Date:  2013-01-16       Impact factor: 4.652

10.  Integrin α3β1 controls mRNA splicing that determines Cox-2 mRNA stability in breast cancer cells.

Authors:  Sita Subbaram; Scott P Lyons; Kimberly B Svenson; Sean L Hammond; Lorena G McCabe; Sridar V Chittur; C Michael DiPersio
Journal:  J Cell Sci       Date:  2014-01-16       Impact factor: 5.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.